(-0.27%) 4 288.05 points
(-0.47%) 33 508 points
(0.14%) 13 219 points
(0.39%) $91.14
(-1.02%) $2.90
(-0.31%) $1 860.40
(-1.67%) $22.08
(1.38%) 919.30
(0.06%) 0.946
(0.12%) 10.71
(0.08%) 0.820
(0.00%) 96.48
Live Chart Being Loaded With Signals
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications...
Stats | |
---|---|
Today's Volume | 6 001.00 |
Average Volume | 254 261 |
Market Cap | 12.58M |
P/E | -0.760 |
ATR14 | $0.0250 (4.03%) |
Ainos, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ainos, Inc. Financials
Annual | 2022 |
Revenue: | $3.52M |
Gross Profit: | $1.41M (39.93 %) |
EPS: | $-1.030 |
Q2 | 2023 |
Revenue: | $28 555.00 |
Gross Profit: | $-27 262.00 (-95.47 %) |
EPS: | $-0.120 |
Q1 | 2023 |
Revenue: | $49 164.00 |
Gross Profit: | $-51 684.00 (-105.13 %) |
EPS: | $-0.130 |
Q4 | 2022 |
Revenue: | $1.04M |
Gross Profit: | $459 815 (44.30 %) |
EPS: | $-0.160 |
Ainos, Inc.
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.